Skip to main content
. 2023 Feb 17;37(2):153–166. doi: 10.1007/s40290-023-00462-2

Table 2.

Characteristics of included studies

Characteristic Clinical trials (n = 20) Observational studies (n = 30)
Geographic location, n (%)
 Asiaa 11 (55%) 11 (37%)b
 Europe 6 (30%) 13 (44%)
 North America 2 (1%) 3 (10%)
 South America 0 (0%) 1 (3%)
 Africa 0 (0%) 1 (3%)
 Multiple countries 1 (5%) 0 (0%)
 Not reported 0 (0%) 1 (3%)
Study setting, n (%)
 Inpatient 1 (5%) 6 (20%)
 Outpatient 7 (35%) 13 (44%)
 Inpatient and outpatient 4 (20%) 1 (3%)
 Not reported 8 (40%) 10 (33%)
Enrolment period, n (%)
 After 2000 9 (45%) 12 (40%)
 Before 2000 1 (5%) 5 (17%)
 Not reported 10 (50%) 13 (43%)

aIncluding Turkey as an Asian country (Turkey is situated in both Asia and Europe, with its larger territory lying on the Asian continent)

bIncluding Russia